A platform for research: civil engineering, architecture and urbanism
RADIOPHARMACEUTICAL ADMINISTRATION FACILITY
To provide a radiopharmaceutical administration facility that can reduce or eliminate movement of an object person after administering a radiopharmaceutical.SOLUTION: A radiopharmaceutical administration facility 100 comprises a treatment and waiting room 104 in which a radiopharmaceutical is administered to a subject 50 and the subject 50 waits for a predetermined time after administration of the radiopharmaceutical. In the treatment and waiting room 104, a radiopharmaceutical can be administered to the subject 50. Thereafter, the subject 50 can wait for a predetermined time in the treatment and waiting room 104 that is the same room, without moving to another room. In the radiopharmaceutical administration facility according to a comparative example, administration was performed in a treatment room 105 for about 5 minutes, and the subject 50 moved to a standby recovery room 109 and waited for about 50 minutes. On the other hand, in the treatment and waiting room 104, administration and waiting can be performed in the same room.SELECTED DRAWING: Figure 2
【課題】放射性薬剤投与後の対象者の移動を低減、または無くすことができる放射性薬剤投与設備を提供する。【解決手段】本実施形態に係る放射性薬剤投与設備100は、被験者50への放射性薬剤の投与と、放射性薬剤の投与後の所定時間の被験者50の待機と、を行う処置待機室104を備える。当該処置待機室104では、被験者50への放射性薬剤の投与を行うことができる。その後、被験者50は、他の部屋へ移動しなくとも、同じ部屋である処置待機室104にて、所定時間の待機を行うことができる。比較例に係る放射性薬剤投与設備において、処置室105にて約5分の投与が行われ、被験者50が待機回復室109へ移動して約50分の待機が行われた。これに対し、処置待機室104では、同じ室内にて、投与と待機を行うことができる。【選択図】図2
RADIOPHARMACEUTICAL ADMINISTRATION FACILITY
To provide a radiopharmaceutical administration facility that can reduce or eliminate movement of an object person after administering a radiopharmaceutical.SOLUTION: A radiopharmaceutical administration facility 100 comprises a treatment and waiting room 104 in which a radiopharmaceutical is administered to a subject 50 and the subject 50 waits for a predetermined time after administration of the radiopharmaceutical. In the treatment and waiting room 104, a radiopharmaceutical can be administered to the subject 50. Thereafter, the subject 50 can wait for a predetermined time in the treatment and waiting room 104 that is the same room, without moving to another room. In the radiopharmaceutical administration facility according to a comparative example, administration was performed in a treatment room 105 for about 5 minutes, and the subject 50 moved to a standby recovery room 109 and waited for about 50 minutes. On the other hand, in the treatment and waiting room 104, administration and waiting can be performed in the same room.SELECTED DRAWING: Figure 2
【課題】放射性薬剤投与後の対象者の移動を低減、または無くすことができる放射性薬剤投与設備を提供する。【解決手段】本実施形態に係る放射性薬剤投与設備100は、被験者50への放射性薬剤の投与と、放射性薬剤の投与後の所定時間の被験者50の待機と、を行う処置待機室104を備える。当該処置待機室104では、被験者50への放射性薬剤の投与を行うことができる。その後、被験者50は、他の部屋へ移動しなくとも、同じ部屋である処置待機室104にて、所定時間の待機を行うことができる。比較例に係る放射性薬剤投与設備において、処置室105にて約5分の投与が行われ、被験者50が待機回復室109へ移動して約50分の待機が行われた。これに対し、処置待機室104では、同じ室内にて、投与と待機を行うことができる。【選択図】図2
RADIOPHARMACEUTICAL ADMINISTRATION FACILITY
放射性薬剤投与設備
IWATA TOMOYA (author)
2023-10-05
Patent
Electronic Resource
Japanese
IPC:
E04H
Gebäude oder ähnliche Bauwerke für besondere Zwecke
,
BUILDINGS OR LIKE STRUCTURES FOR PARTICULAR PURPOSES
Process for producing astatine-211 for radiopharmaceutical use
Elsevier | 1988
|RADIONUCLIDE-CONTAINING SUBSTANCE ADMINISTRATION FACILITY
European Patent Office | 2024
|RADIONUCLIDE-CONTAINING SUBSTANCE ADMINISTRATION FACILITY UNIT
European Patent Office | 2024
|